Ziopharm Oncology

Ziopharm Oncology

Biotechnology, 8030 El Rio St, Houston, Texas, 77054, United States, 51-200 Employees

alaunos.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 61********

Who is ZIOPHARM ONCOLOGY

Alaunos Therapeutics is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty g...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 325414 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ZIOPHARM ONCOLOGY

Ziopharm Oncology Org Chart and Mapping

Kevin Boyle

Chief Executive Officer

VP-Level
Employees

Brittany Hines

Customer Service Representative

Mariam Khalil

Biomarker Discovery Scientist II

Jan Stevens

Senior Director, Clinical Operations

Drew Deniger

VP, Research, Development

Kevin Lafond

Senior Vice President Finance, Chief Accounting Officer, Treasurer

Victor Carpio

Associate Director of Analytical Development and Quality Control

Amanda Montoya

Sr. Manufacturing Associate

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Ziopharm Oncology

Answer: Ziopharm Oncology's headquarters are located at 8030 El Rio St, Houston, Texas, 77054, United States

Answer: Ziopharm Oncology's phone number is 61********

Answer: Ziopharm Oncology's official website is https://alaunos.com

Answer: Ziopharm Oncology's revenue is $50 Million to $100 Million

Answer: Ziopharm Oncology's SIC: 2836

Answer: Ziopharm Oncology's NAICS: 325414

Answer: Ziopharm Oncology has 51-200 employees

Answer: Ziopharm Oncology is in Biotechnology

Answer: Ziopharm Oncology contact info: Phone number: 61******** Website: https://alaunos.com

Answer: Alaunos Therapeutics is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform and its unique cancer mutation hotspot TCR library, targeting common tumor-related mutations in key oncogenic genes including KRAS, TP53 and EGFR.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access